Clinical trial
Persistence of Protection Conferred by Shingrix Against Herpes Zoster
NCT04169009 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Persistence of Protection Conferred by Shingrix Against Herpes Zoster
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 28, 2020
- Completion date
- June 13, 2024
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.